|Bid||244.30 x N/A|
|Ask||245.65 x N/A|
|Day's range||244.60 - 246.20|
|52-week range||221.00 - 299.60|
|Beta (5Y monthly)||0.87|
|PE ratio (TTM)||46.54|
|Forward dividend & yield||1.02 (0.40%)|
|Ex-dividend date||29 Sept 2022|
|1y target est||N/A|
HTHIY vs. DHR: Which Stock Is the Better Value Option?
Catalent (CTLT) shares gain significantly, following a Bloomberg report about a potential acquisition of the CDMO company by Danaher, a life sciences company.
(Bloomberg) -- Life sciences company Danaher Corp. has expressed takeover interest in contract manufacturer Catalent Inc., according to people familiar with the matter. Most Read from BloombergMeta Asks Many Managers to Get Back to Making Things or LeaveGeorge Santos Gets Into Fight With Mitt Romney at State of the Union DebutChinese Balloon Was Part of Years-Long Spying Program, US SaysDeSantis Chides Trump as Republicans’ 2024 Presidential Race Heats UpDisney Jumps on Iger’s $5.5 Billion Savin